Qin Yuanyuan, Song Ting, Su Bin, Jiao Yanmei, Liu Lifeng, Liu Zhiying, Zhou Yihong, Chen Yaokai, Wu Hao
Beijing Key Laboratory for HIV/AIDS Research, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China.
HIV Med. 2022 Mar;23 Suppl 1:6-13. doi: 10.1111/hiv.13244.
Although antiretroviral therapy (ART) has prolonged the lives of HIV-infected individuals, HIV reservoir remains the main stumbling block to HIV cure. Presently, early ART initiation is one of the effective measures to reduce the HIV reservoir. The effects of ART in Chinese individuals with acute and early HIV infection (AEHI) and chronic HIV infection (CHI) were analyzed in this study.
We performed virological and immunological parameter analysis in 29 AEHI and 19 CHI individuals who were initiated into ART in Beijing, China. The HIV DNA, CD4 T-cell and CD8 T-cell counts, and CD4/CD8 ratios between the two groups were compared using statistical analyses.
At weeks 48 and 96, the total HIV DNA was significantly lower in the AEHI group than that the CHI group (2.48 [2.26-2.66] vs. 3.06 [2.79-3.33] log10 copies/10 peripheral blood mononuclear cells (PBMCs), p < 0.01 at week 48 and 2.17 [1.85-2.45] vs. 2.92 [2.73-3.24] log10 copies/10 PBMCs, p < 0.01 at week 96, respectively). The CD4/CD8 T-cell ratio in the AHI group at week 24 was significantly higher than that in the CHI group (0.71 [0.50-0.99] vs. 0.45 [0.34-0.65], p = 0.08). After 48 weeks of ART, there was still a negative correlation between the CD4/CD8 ratio and the HIV DNA level in the CHI group rather than the AEHI group.
Early ART initiation could enhance an earlier immunological recovery in AEHI. Immunological normalization after ART initiation could provide important protection against the viral reservoir seeded in AEHI individuals.
尽管抗逆转录病毒疗法(ART)延长了HIV感染者的生命,但HIV储存库仍然是治愈HIV的主要障碍。目前,尽早开始ART是减少HIV储存库的有效措施之一。本研究分析了ART在中国急性和早期HIV感染(AEHI)及慢性HIV感染(CHI)个体中的效果。
我们对在中国北京开始接受ART的29例AEHI个体和19例CHI个体进行了病毒学和免疫学参数分析。使用统计分析比较了两组之间的HIV DNA、CD4 T细胞和CD8 T细胞计数以及CD4/CD8比值。
在第48周和第96周时,AEHI组的总HIV DNA显著低于CHI组(分别为2.48[2.26 - 2.66]对3.06[2.79 - 3.33]log10拷贝/10外周血单个核细胞(PBMC),第48周时p < 0.01;以及2.17[1.85 - 2.45]对2.92[2.73 - 3.24]log10拷贝/10 PBMC,第96周时p < 0.01)。AHI组在第24周时的CD4/CD8 T细胞比值显著高于CHI组(0.71[0.50 - 0.99]对0.45[0.34 - 0.65],p = 0.08)。ART治疗48周后,CHI组而非AEHI组的CD4/CD8比值与HIV DNA水平之间仍呈负相关。
尽早开始ART可促进AEHI个体更早的免疫恢复。ART开始后的免疫正常化可为预防AEHI个体中植入的病毒储存库提供重要保护。